Hostname: page-component-78c5997874-ndw9j Total loading time: 0 Render date: 2024-11-18T18:53:15.380Z Has data issue: false hasContentIssue false
  • English
  • Français

QuantiFERON-TB Testing for Latent Tuberculosis Infection in Low-Prevalence Countries: Making the Most of an Imperfect Process

Published online by Cambridge University Press:  02 January 2015

William J. Schneider ,
Arthur E. Brown  and
Cynthia Eisenstein
William J. Schneider*
Affiliation:
Employee Health and Wellness Services, Memorial Sloan-Kettering Cancer Center, New York, New York Weill Cornell Medical College, New York, New York
Arthur E. Brown
Affiliation:
Employee Health and Wellness Services, Memorial Sloan-Kettering Cancer Center, New York, New York Weill Cornell Medical College, New York, New York
Cynthia Eisenstein
Affiliation:
Employee Health and Wellness Services, Memorial Sloan-Kettering Cancer Center, New York, New York
*
Employee Health and Wellness Services, Memorial Sloan-Kettering Cancer Center, 222 East 70th Street, New York, NY 10021 (schneidw@mskcc.org)
Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Letters to the Editor
Information
Infection Control & Hospital Epidemiology , Volume 32 , Issue 10 , October 2011 , pp. 1055
Copyright
Copyright © The Society for Healthcare Epidemiology of America 2011

References

1. Gandra, S, Scott, WS, Somaraju, V, Wang, H, Wilton, S, Feigenbaum, M. Questionable effectiveness of the QuantiFERON test (Celles-tis) as a screening tool in healthcare workers. Infect Control Hosp Epidemiol 2010;31:1279–1285.Google Scholar
2. Gandra, S, Scott, WS, Somaraju, V. Reply to Joshi et al. Infect Control Hosp Epidemiol 2011;32:518–519.Google Scholar
3. Joshi, M, Monson, T, Woods, G. Practical experience with the QFT-GIT assay for LTBI annual testing among US heath-care workers in a large tertiary setting. Chest 2010;138:746A.Google Scholar
4. Joshi, M, Monson, T, Woods, G. QuantiFERON-TB test for annual screening of healthcare workers: not yet ready for prime time in low-prevalence countries. Infect Control Hosp Epidemiol 2011;32:518.Google Scholar
5. Schneider, WJ, Eisenstein, C, Brown, AE, Patel, PH. Higher than expected annual QuantiFERON-Gold (QFT-G) “conversion” rate suggests a need for redefining reactivity criteria in healthcare workers (HCWs). 47th annual meeting of the Infectious Diseases Society of America, 29 October-1 November 2009; Philadelphia.Google Scholar
6. Schneider, WJ, Brown, AE, Eisenstein, C. Successive comparative observations of test results using QuantiFERON-Gold (QFT-G) and QuantiFERON-Gold In Tube (QFT-GIT): implications in a health worker setting. 48th annual meeting of the Infectious Diseases Society of America, 23 October 2010; Vancouver. Abstract 4947; poster LB-24.Google Scholar
7. Brown, AE, Eisenstein, C, Schneider, WJ, Kiehn, TE, Glickman, M. Results of QuantiFERON-TB Gold (QFT-G) testing of employees in a healthcare setting. 45th annual meeting of the Infectious Diseases Society of America, 4-7 October 2007; San Diego, CA. Abstract LB-12.Google Scholar
8. Harada, N, Higuchi, K, Yoshiyama, T, et al. Comparison of the sensitivity and specificity of two whole blood interferon-gamma assays for M. tuberculosis infection . J Infect 2008;56:348–353.Google Scholar